Deuremidevir Hydrobromide for Suspension

DRUG2 trials

Sponsors

Vigonvita Life Sciences

Conditions

Respiratory Syncytial Virus InfectionRespiratory Syncytial Virus Infections

Phase 1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

CompletedNCT06328400

Vigonvita Life SciencesRespiratory Syncytial Virus Infections

Start: 2024-03-27End: 2024-05-06Updated: 2024-10-01

Phase 2

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

CompletedNCT06206720

Vigonvita Life SciencesRespiratory Syncytial Virus Infection

Start: 2024-01-31End: 2025-06-16Updated: 2025-07-23